SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025273
Filing Date
2020-05-14
Accepted
2020-05-14 07:43:25
Documents
68
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q freq-10q_20200331.htm 10-Q 2339929
2 EX-31.1 freq-ex311_108.htm EX-31.1 17970
3 EX-31.2 freq-ex312_107.htm EX-31.2 18009
4 EX-32.1 freq-ex321_109.htm EX-32.1 9537
5 EX-32.2 freq-ex322_110.htm EX-32.2 9568
  Complete submission text file 0001564590-20-025273.txt   7202133

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT freq-20200331.xml EX-101.INS 1345851
7 XBRL TAXONOMY EXTENSION SCHEMA freq-20200331.xsd EX-101.SCH 52463
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE freq-20200331_cal.xml EX-101.CAL 49913
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE freq-20200331_def.xml EX-101.DEF 169062
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20200331_lab.xml EX-101.LAB 434591
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20200331_pre.xml EX-101.PRE 327832
Mailing Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 20875306
SIC: 2834 Pharmaceutical Preparations